Discover published sets by community

The process of collecting biological samples must respect athlete's dignity and privacy.

Athletes have the right to appeal doping violations and sanctions.

Athletes' personal data collected during testing must be handled in accordance with privacy laws and regulations.

Athletes must disclose any banned substances they have taken when asked during doping control.

Trained professionals responsible for the collection of doping samples from athletes.

Stored samples can be retested with new technology as anti-doping science advances.

Drug tests can occur without warning outside of events to deter year-round doping.

Athletes have the right to a representative and an interpreter during the testing process.

Athletes must give informed consent before undergoing drug testing.

Athletes and organizations must comply with the World Anti-Doping Agency (WADA) Code.

The sample must be secured and tracked from collection to analysis to ensure integrity.

Consequences for doping violations can include disqualification, loss of results, and bans from sport.

A longitudinal profile of an athlete's biomarkers of doping and doping-related effects.

Athletes can apply for TUEs to take necessary medications that are on the prohibited list for medical reasons.

An AAF is reported when a prohibited substance or method is identified in a sample.

Standardized protocols must be followed during drug testing to ensure fairness and accuracy.

WADA publishes a list of substances and methods that are prohibited in and out of competition.

Laboratories conducting drug tests must adhere to strict scientific and technical guidelines.

Educating athletes on the rules and risks of doping is a crucial aspect of prevention.